Unknown

Dataset Information

0

Multiomics Reveals Ectopic ATP Synthase Blockade Induces Cancer Cell Death via a lncRNA-mediated Phospho-signaling Network.


ABSTRACT: The EGFR tyrosine kinase inhibitor gefitinib is commonly used for lung cancer patients. However, some patients eventually become resistant to gefitinib and develop progressive disease. Here, we indicate that ecto-ATP synthase, which ectopically translocated from mitochondrial inner membrane to plasma membrane, is considered as a potential therapeutic target for drug-resistant cells. Quantitative multi-omics profiling reveals that ecto-ATP synthase inhibitor mediates CK2-dependent phosphorylation of DNA topoisomerase IIα (topo IIα) at serine 1106 and subsequently increases the expression of long noncoding RNA, GAS5. Additionally, we also determine that downstream of GAS5, p53 pathway, is activated by ecto-ATP synthase inhibitor for regulation of programed cell death. Interestingly, GAS5-proteins interactomic profiling elucidates that GAS5 associates with topo IIα and subsequently enhancing the phosphorylation level of topo IIα. Taken together, our findings suggest that ecto-ATP synthase blockade is an effective therapeutic strategy via regulation of CK2/phospho-topo IIα/GAS5 network in gefitinib-resistant lung cancer cells.

SUBMITTER: Chang YW 

PROVIDER: S-EPMC7664121 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Multiomics Reveals Ectopic ATP Synthase Blockade Induces Cancer Cell Death via a lncRNA-mediated Phospho-signaling Network.

Chang Yi-Wen YW   Hsu Chia-Lang CL   Tang Cheng-Wei CW   Chen Xiang-Jun XJ   Huang Hsuan-Cheng HC   Juan Hsueh-Fen HF  

Molecular & cellular proteomics : MCP 20200811 11


The EGFR tyrosine kinase inhibitor gefitinib is commonly used for lung cancer patients. However, some patients eventually become resistant to gefitinib and develop progressive disease. Here, we indicate that ecto-ATP synthase, which ectopically translocated from mitochondrial inner membrane to plasma membrane, is considered as a potential therapeutic target for drug-resistant cells. Quantitative multi-omics profiling reveals that ecto-ATP synthase inhibitor mediates CK2-dependent phosphorylation  ...[more]

Similar Datasets

| S-EPMC4260757 | biostudies-literature
| S-EPMC8593108 | biostudies-literature
2023-05-10 | PXD007036 | Pride
2023-05-22 | PXD014995 | Pride
| S-EPMC10272197 | biostudies-literature
2015-11-06 | PXD000701 | Pride
2023-05-10 | PXD006791 | Pride
2015-11-06 | PXD000696 | Pride
| S-EPMC6720485 | biostudies-literature
| S-EPMC3749231 | biostudies-literature